Kliniske studier for Gliom i Alabama
6 studier for Gliom søker deltakere på steder i Alabama.
Byer i Alabama
Offisiell studietekst (engelsk)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital of Alabama, Birmingham
RekruttererFase 1/2
12 Months – 21 Years · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07326566HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
RekruttererFase 1
36 Months – 22 Years · Alle kjønn · Oppdatert 4. sep. 2026 · NCT03911388SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Alabama, Birmingham
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05303519Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
- UAB, Birmingham
- UAB, Birmingham
RekruttererTidlig fase 1
Alder 10 til 89 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05632562Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- University of Alabama at Birmingham, Children's of Alabama, Birmingham
RekruttererFase 1
Alder 1 til 25 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT04485559Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.